Ovid Therapeutics Inc.

GOLDMAN SACHS GROUP INC OVID

Report date

12/31/2025

Quarter

2025 Q4

Filed

3/25/2026

Shares

170,457

Value ($000)

278

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	3/25/2026	278	0.0%	170,457	12/31/2025
2025 Q3	11/14/2025	37	0.0%	28,517	9/30/2025
2025 Q2	8/14/2025	94	0.0%	283,824	6/30/2025
2025 Q1	6/27/2025	33	0.0%	104,435	3/31/2025
2024 Q4	2/11/2025	185	0.0%	198,123	12/31/2024
2024 Q3	11/14/2024	154	0.0%	130,279	9/30/2024
2024 Q2	8/13/2024	98	0.0%	126,826	6/30/2024
2024 Q1	5/15/2024	180	0.0%	58,984	3/31/2024
2023 Q4	5/14/2024	199	0.0%	61,795	12/31/2023
2023 Q3	5/15/2024	218	0.0%	56,756	9/30/2023
2023 Q2	5/14/2024	217	0.0%	66,122	6/30/2023
2023 Q1	5/14/2024	29	0.0%	11,174	3/31/2023
2022 Q4	5/14/2024	28	0.0%	15,155	12/31/2022
2022 Q3	5/14/2024	67	0.0%	36,074	9/30/2022
2022 Q2	5/14/2024	94	0.0%	43,601	6/30/2022
2022 Q1	5/16/2022	143	0.0%	45,347	3/31/2022
2021 Q4	2/17/2022	158	0.0%	49,389	12/31/2021
2021 Q3	1/20/2022	328	0.0%	97,545	9/30/2021
2021 Q2	8/13/2021	444	0.0%	113,572	6/30/2021
2021 Q1	5/17/2021	3,021	0.0%	751,565	3/31/2021
2020 Q4	2/12/2021	1,096	0.0%	474,545	12/31/2020
2020 Q3	11/13/2020	296	0.0%	51,513	9/30/2020
2020 Q2	8/12/2020	845	0.0%	114,674	6/30/2020
2020 Q1	5/15/2020	406	0.0%	136,251	3/31/2020
2019 Q4	2/14/2020	355	0.0%	85,512	12/31/2019